I agree Misiu. Rationally, just to me again, it d

I agree Misiu. Rationally, just to me again, it does not make much sense if they do not allow CYDY to include these patients since they already are meeting or exceeding safety, efficacy, and lack of resistance with this dose to any other HAART regimen already on the market. Also there has been significant delay in submitting pivotal trial structure to FDA. My thoughts are this was not just due to lack of financing but also that both sides may have finally come to some understanding after reviewing these patients' data to date. Maybe the new 700mg patients--and maybe some new 525 mg patients will be included also?--will be better screened with the new CCR5 test and also overlap with HAART for 5+weeks rather than just 1 week to hit even higher efficacy rates. Again all just IMO.

Lastly, after today's post, it is hard to give Finesand the benefit of the doubt anymore--this was just spreading FUD.